The low expression of DNAM-1 on tumour-infiltrating NK cells should be considered carefully since modulating the inhibitory part of the axis can only be effective if the activating ligands (DNAM-1) are highly expressed and the activating part of the axis is functional. This evidence concerns the gene CD226 and neoplasm.